Document Detail

Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure.
MedLine Citation:
PMID:  21264074     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Many clinical studies have documented favourable effects (reduced morbidity and mortality) of beta-adrenoceptor (β-AR) antagonists, such as carvedilol, metoprolol, propranolol, atenolol and bisoprolol, in congestive heart failure. These agents attenuate the effects of sympathetic activation during the development of heart failure, prevent ventricular remodelling and improve cardiac function. Because β-AR blockers are known to exert negative inotropic action, the mechanisms responsible for their beneficial effects in heart failure have been a subject of debate. While attenuation of changes in β-AR cyclic AMP-mediated signal transduction in heart failure is considered to be responsible for the beneficial effects of β-AR antagonists, other mechanisms such as the effects of these agents on subcellular remodelling, oxidative stress, apoptosis and defect in calcium handling, are equally important in preventing cardiac alterations in the failing heart. Moreover, β-AR antagonists are not a homogeneous group of drugs because they differ in their pharmacokinetics and pharmacodynamics, in addition to the selective and nonselective nature of their actions on β-AR. Various β-AR blocking agents have been shown to possess different ancillary properties and produce effects that are independent of β-AR. In fact, different β-AR antagonists have been observed to lower the elevated levels of plasma catecholamines in heart failure. Thus, the beneficial effects of β-AR antagonists are not only elicited through their interaction with mediated β-AR signal transduction sites in the myocardium, but other mechanisms may also contribute to their favourable actions in heart failure.
Navneet S Rehsia; Naranjan S Dhalla
Related Documents :
22612284 - Trajectories for frontal external ventricular drain placement: virtual cannulation of a...
16274414 - Multicenter automatic defibrillator implantation trial-cardiac resynchronization therap...
12950514 - Cardiac resynchronization therapy is an important advance in the management of congesti...
21686364 - An unusual case of infective endocarditis presenting as acute myocardial infarction.
19014564 - Atypical presentation of "takotsubo cardiomyopathy" without st segment elevation: a cas...
233324 - Role of cyclic amp in myocardial cell function.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Experimental and clinical cardiology     Volume:  15     ISSN:  1918-1515     ISO Abbreviation:  Exp Clin Cardiol     Publication Date:  2010  
Date Detail:
Created Date:  2011-01-25     Completed Date:  2011-07-14     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  9715903     Medline TA:  Exp Clin Cardiol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  e86-95     Citation Subset:  -    
Institute of Cardiovascular Sciences, St Boniface Hospital Research Centre;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Vascular smooth muscle cell motility: From migration to invasion.
Next Document:  Hypokalemia and sudden cardiac death.